✦ LIBER ✦

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis

✍ Scribed by Ana-Carolina Cardoso; Rami Moucari; Claudio Figueiredo-Mendes; Marie-Pierre Ripault; Nathalie Giuily; Corinne Castelnau; Nathalie Boyer; Tarik Asselah; Michelle Martinot-Peignoux; Sarah Maylin; Roberto J. Carvalho-Filho; Dominique Valla; Pierre Bedossa; Patrick Marcellin

Book ID: 116652084
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 534 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2009.12.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintenance Peginterferon Therapy and Ot

Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C

✍ Anna S. Lok; James E. Everhart; Elizabeth C. Wright; Adrian M. Di Bisceglie; Hae 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 560 KB

65 PEGINTERFERON AND RIBAVIRIN THERAPY I

65 PEGINTERFERON AND RIBAVIRIN THERAPY IMPROVE PROGNOSIS IN PATIENTS AFTER CURATIVE TREATMENT OF HEPATOCELLULAR CARCINOMA-ASSOCIATED HEPATITIS C

✍ K. Tsuchiya; Y. Asahina; N. Tamaki; I. Hirayama; Y. Yasui; T. Tanaka; M. Sato; T 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Exam 2: Maintenance Peginterferon Therap

Exam 2: Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 72 KB

408 RISK FACTORS FOR DEVELOPMENT OF HEPA

408 RISK FACTORS FOR DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C AFTER SUSTAINED RESPONSE TO PEGINTERFERON AND RIBAVIRIN COMBINATION THERAPY

✍ K.-C. Chang; T.-H. Hu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Efficacy and safety of peginterferon alf

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

✍ Savino Bruno; Mitchell L. Shiffman; Stuart K. Roberts; Edward J. Gane; Diethelm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB 👁 1 views

The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40 KD)/ribavirin in patients with advanced fibrosis. Data from 341 genotype 1/4 patients (99 with bridging fibrosis/cirrhosis) treated for 48 weeks and 1547 genotype 2/3 patients (380 with bridging fibrosis

Effect of interferon α-2b plus ribavirin

Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis

✍ Mika Kurokawa; Naoki Hiramatsu; Tsugiko Oze; Kiyoshi Mochizuki; Takayuki Yakushi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB